Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Hydrogen (H2) is colorless, odorless, and the lightest of gas molecules. Studies in the past ten years have indicated that H2 is extremely important in regulating the homeostasis of the cardiovascular system and metabolic activity. Delivery of H2 by various strategies improves cardiometabolic diseas...
Main Authors: | Yaxing Zhang, Sihua Tan, Jingting Xu, Tinghuai Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-05-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/489737 |
Similar Items
-
Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
by: Kevin M. Casin, et al.
Published: (2021-03-01) -
High-Energy Phosphates and Ischemic Heart Disease: From Bench to Bedside
by: Hao Yi-Dan, et al.
Published: (2021-07-01) -
Sphingolipid lysosomal storage diseases: from bench to bedside
by: Muna Abed Rabbo, et al.
Published: (2021-05-01) -
Editorial: Medicinal Plants for Cardiovascular and Neurodegenerative Aging-Related Diseases: From Bench to Bedside
by: Yue Liu, et al.
Published: (2020-09-01) -
Cardiovascular Disease and Diabetes: A Journey From Bench to Bedside
Published: (2019)